The Life Sciences landscape is being reshaped by rapid scientific advancements and abundant capital coupled with shifting demographics and public policy.
Encompassing everything from basic science and small molecules through complex therapeutic solutions and incredibly sophisticated equipment, all Life Sciences companies share a common, primary mission of improving human health.
Bowen’s Life Sciences practice serves clients in the BioPharma, Medical Device and Diagnostics sectors. Our team’s key differentiating factor is our unique combination of deep scientific and domain-specific expertise coupled with decades of operating and transactional experience. No matter how complex the underlying science, clinical/regulatory strategy or competitive landscape, we will firmly grasp your unique value propositions, goals and needs.
We specialize in private capital financings as well as both sellside and buyside strategic transactions. Given our unique background, we are the partner of choice for clients ranging from the late preclinical or beta testing stages through mature, commercial-stage companies. Our team has helped Life Sciences companies raise over $2 billion in capital and complete over $4 billion in transactions. Our Life Sciences and Healthcare Tech practices complement each other and frequently collaborate on clients who straddle sectors.